Aerocort Inhaler
Generic: Beclometasone/Levosalbutamolby Cipla Limited

Select pack size
Similar medicines
View allAbout Aerocort Inhaler
Aerocort Inhaler is a pressurised metered dose inhaler made in India by Cipla. Cipla's prescribing information says each puff (actuation) delivers beclometasone dipropionate 50 mcg, an inhaled corticosteroid (a preventer), plus levosalbutamol 50 mcg, a short-acting bronchodilator (a reliever, called levalbuterol in the US), suspended in an HFA-134a propellant. One canister holds 200 metered doses. We sell it in packs of 1, 2 and 3 inhalers, from $10.00 an inhaler in the 3 inhaler pack.
This page covers what the Cipla leaflet says about dose, how that dose fits asthma guidelines, how it compares with US products, how to use a pressurised inhaler, side effects, when to get urgent help, who should not use it and the price per puff. Clinical figures come from the Cipla prescribing information and from US and UK labels for each ingredient, listed at the end. We have not found a published trial of this beclometasone and levosalbutamol inhaler.
Read this before you order. This product puts a preventer and a reliever in one fixed dose. Cipla's leaflet says two inhalations three or four times daily and that it is "not for use in acute attacks, but for routine long-term management". Taken that way, you also take a reliever three or four times every day, and the Global Initiative for Asthma (GINA) says "Regular use of SABA is not recommended" (SABA means short-acting beta2 agonist, the type of reliever levosalbutamol is). Taken only when you have symptoms, it resembles an approach GINA does support, but the leaflet does not describe that use. We found no product with this combination approved by the FDA, MHRA, TGA or Health Canada. We would not recommend it: licensed options exist, including separate preventer and reliever inhalers, budesonide with formoterol, and in the US, Airsupra. If you and your doctor still decide on it, use it only on a written plan, and keep a separate reliever your doctor has agreed.
Aerocort Inhaler at a glance
| Active ingredients | Beclometasone dipropionate 50 mcg and levosalbutamol (as sulphate) 50 mcg per actuation (Cipla prescribing information; Truemeds, PharmEasy, Apollo and Medkart list the same) |
| Brand and maker | Aerocort, by Cipla Limited, India (PharmEasy names a Cipla site in Kumrek, Rangpo, Sikkim) |
| Form | Inhalation aerosol (pressurised metered dose inhaler), canister of 200 metered doses; Cipla's packaging line reads "AEROCORT Inhaler with Dose Counter" |
| Regulatory status | Not approved by the FDA, MHRA, TGA or Health Canada. We found no beclometasone with levosalbutamol (or salbutamol) inhaler licensed in the US, UK or Canada, and could not confirm one in Australia. The UK's beclometasone with salbutamol inhaler from GSK (Ventide) is listed by the NHS dictionary of medicines as discontinued. |
| Usual dose from the Cipla label | Adults and adolescents 12 years and above: two inhalations three or four times daily, "titrated to the lowest effective dose". That is 6 to 8 puffs a day, or 300 to 400 mcg of beclometasone and 300 to 400 mcg of levosalbutamol a day (our arithmetic). |
| Timing | No timing data for Aerocort itself. For each ingredient alone, US labels give: levalbuterol inhaler, median 5.5 to 10.2 minutes to a 15% rise in lung function (FEV1) on day 1, and a median duration of effect of 3 to 4 hours in responders; beclometasone inhaler, improvement in symptoms can occur within 24 hours, "maximum benefit should not be expected until 3 to 4 weeks of therapy" |
| Packs | 1, 2 and 3 inhalers, 200 puffs each |
| Price per puff | $0.055 (1 or 2 inhalers) and $0.05 (3 inhalers), before shipping |
| Delivery | 7 to 14 business days to the US, UK, Australia and Canada; $25 shipping under $149, free from $149 |
Price per inhaler and per puff
Prices below are as of November 2026. The pack selector above always shows the current price.
| Pack | Price | Per inhaler | Per puff (200 a canister) | Shipping | Per inhaler with shipping | Lasts at the label dose (our estimate) |
|---|---|---|---|---|---|---|
| 1 inhaler | $11.00 | $11.00 | $0.055 | $25 | $36.00 | About 25 to 33 days |
| 2 inhalers | $22.00 | $11.00 | $0.055 | $25 | $23.50 | About 50 to 66 days |
| 3 inhalers | $30.00 | $10.00 | $0.05 | $25 | $18.33 | About 75 to 100 days |
All three packs are under the $149 free shipping threshold, so the flat $25 shipping costs more than one inhaler does. Before shipping, the 2 inhaler pack costs the same per inhaler as the single inhaler; only the 3 inhaler pack is cheaper per inhaler. The last column is our own arithmetic at the Cipla label dose of 6 to 8 puffs a day; test sprays used to prime the inhaler come out of the same 200, so the real figure is a little lower. In India, Truemeds, PharmEasy and Medkart list a maximum retail price of Rs 341.59 for one inhaler.
Compared with US products
There is no US, UK, Canadian or Australian version of this exact combination to compare it with. The nearest licensed products are below. US prices are NADAC, which is what US pharmacies pay, not a retail price.
| Aerocort Inhaler | QVAR RediHaler (US) | Levalbuterol inhaler (US) | Airsupra (US) | |
|---|---|---|---|---|
| What it contains | Beclometasone 50 mcg + levosalbutamol 50 mcg per puff | Beclometasone 40 or 80 mcg per puff (preventer only) | Levalbuterol 45 mcg per puff (reliever only) | Albuterol (salbutamol) 90 mcg + budesonide 80 mcg per puff |
| Maker | Cipla, India | Teva | Xopenex HFA (Lupin) and generics | AstraZeneca |
| FDA approved | No | Yes, for regular preventer use, age 4 and over | Yes, age 4 and over | Yes, as needed only, adults 18 and over |
| Puffs per inhaler | 200 | 120 | 200 | 120 |
| US pharmacy cost per inhaler (NADAC, rates effective 21 October 2026) | Ours: $10.00 to $11.00 an inhaler before shipping | About $218 (40 mcg) and $292 (80 mcg) | About $53 (generic) and $75 (Xopenex HFA) | About $482 |
The NADAC figures are per gram rates times the canister weight in each US label (our arithmetic): QVAR RediHaler $20.55617 and $27.55474 per gram, 10.6 g; generic levalbuterol tartrate inhaler $3.55375 and Xopenex HFA $4.98458 per gram, 15 g; Airsupra $45.02695 per gram, 10.7 g. These were the latest rows in the NADAC file dated 4 November 2026. Generic beclometasone dipropionate inhalers are also sold in the US (DailyMed lists Aurolife and Amneal labels), but we found no NADAC row for them. Our price is far lower, but it is not the same product: none of these is a beclometasone and levosalbutamol inhaler. Microgram doses do not swap one for one between beclometasone inhalers either: QVAR is a solution inhaler, and its label says that in children about twice the systemic steroid exposure would be expected from comparable doses of the earlier QVAR inhaler without a spacer as from an older CFC beclometasone inhaler with a large volume spacer (US QVAR label 12.3; our note). Cipla describes Aerocort as a suspension. If you are in the US and have insurance or a prescription, ask your doctor about a licensed option before ordering from abroad.
Airsupra is the only fixed preventer plus short-acting reliever combination we found approved in any of the four countries. Its label limits it to "as-needed treatment or prevention of bronchoconstriction and to reduce the risk of exacerbations" in adults, at 2 puffs as needed, and says "Do not take more than 6 doses (12 inhalations) in a 24-hour period". It contains different medicines from Aerocort, so its trial results do not transfer to Aerocort. We found no Airsupra listing in Health Canada's Drug Product Database or on the UK emc.
Regular use or as needed: what the label and the guidelines say
- The Cipla label says regular use. Two inhalations three or four times daily, for "routine long-term management", "not for use in acute attacks"; "so, some patients will require a separate levosalbutamol inhaler for relief of acute bronchospasm". The label describes the combination as "specially provided for those patients who require regular doses of both drugs".
- The same label also says "Other short-acting sympathomimetic aerosol bronchodilators or epinephrine should not be used concomitantly with levosalbutamol." A separate salbutamol inhaler is that kind of medicine, and a separate levosalbutamol inhaler adds to the levosalbutamol you already take. The leaflet does not say how many reliever puffs in total are safe each day, so ask your doctor which reliever to use and how (our note).
- GINA on regular relievers: "Regular use of SABA is not recommended", because within 1 to 2 weeks it increases airway hyperresponsiveness and airway inflammation and decreases the bronchodilator response (GINA 2026 Summary Guide, non-recommended treatments for adults and adolescents). GINA's reliever recommendations add that regular SABA use "increases allergic responses and airway inflammation, and reduces the bronchodilator response to SABA".
- GINA on reliever only treatment: "For safety, GINA recommends that asthma should not be treated solely with as-needed SABA." Aerocort does contain a steroid, so it is not reliever only treatment.
- GINA on as-needed steroid plus reliever: GINA lists "beclometasone-salbutamol" and budesonide-salbutamol as low dose ICS-SABA combinations, for use as a reliever "instead of SABA" for adults and adolescents in its Track 2. Its preferred reliever is low dose ICS-formoterol, "because it reduces the risk of severe exacerbations, compared with treatment regimens with SABA reliever".
- Trials of the as-needed idea: in one 6 month trial in 455 patients with mild asthma (Papi 2007, PMID 17507703), a single inhaler of beclometasone 250 mcg with salbutamol 100 mcg used as needed led to fewer exacerbations than salbutamol alone, and the authors concluded it was as effective as regular beclometasone. In children aged 5 to 18 with mild persistent asthma (TREXA, PMID 21324520), beclometasone taken with each salbutamol rescue dose, from separate inhalers, gave fewer treatment failures than salbutamol alone; the authors still concluded daily inhaled steroids were the most effective way to prevent exacerbations. Neither trial used levosalbutamol or Aerocort's doses.
Our reading: the labelled regular schedule means daily regular reliever use, which GINA advises against, and using it only as needed is outside the Cipla label and has not been tested with this product. Either way it is a decision for a doctor who knows your asthma. If you need it for symptoms more than your plan allows, the Cipla label says that needing more doses of levosalbutamol than usual "may be a marker of destabilization of asthma".
Which Aerocort to choose
We sell three Aerocort products. This table gives each label dose and what it adds up to a day (our arithmetic). GINA dose bands are for total daily inhaled steroid in adults and adolescents.
| Product | Per dose | Cipla label dose | Per day | GINA adult band for that steroid dose |
|---|---|---|---|---|
| Aerocort Inhaler (this page) | Beclometasone 50 mcg + levosalbutamol 50 mcg per puff | Age 12 and above: two inhalations three or four times daily, "titrated to the lowest effective dose" | Beclometasone 300 to 400 mcg; levosalbutamol 300 to 400 mcg | Low, if counted as a standard beclometasone pressurised inhaler (200 to 500 mcg); GINA's table does not list Aerocort itself |
| Aerocort Rotacap | Beclometasone 100 mcg + levosalbutamol 100 mcg per capsule | Adults and children 4 and above: one Rotacap three or four times daily | Beclometasone 300 to 400 mcg; levosalbutamol 300 to 400 mcg | Medium (beclometasone dry powder: above 200 to 400 mcg) |
| Aerocort Forte Rotacaps | Beclometasone 200 mcg + levosalbutamol 100 mcg per capsule | Age 12 and above: one Rotacap three or four times daily | Beclometasone 600 to 800 mcg; levosalbutamol 300 to 400 mcg | High (beclometasone dry powder: above 400 mcg) |
The inhaler and the Rotacap give the same daily micrograms at the label dose, but GINA places them in different bands because it treats a dry powder and a standard pressurised inhaler differently. The Rotacaps need a separate device and a strong, quick breath; the inhaler needs you to press and breathe in at the same time, or a spacer (our note). Do not switch between them without your doctor.
If your doctor wants the preventer and the reliever in separate devices, Cipla also makes Beclate 200 Inhaler (beclometasone alone) and the relievers Levolin Inhaler (levosalbutamol) and Asthalin Inhaler (salbutamol). GINA's preferred reliever is low dose ICS-formoterol; Cipla's Foracort 200 Inhaler is a budesonide with formoterol inhaler. Which approach suits you is your doctor's decision.
How to use Aerocort Inhaler
Cipla's prescribing information gives the dose but no step by step instructions, so read the leaflet in your carton first. The steps below follow the US instructions for Xopenex HFA, a levalbuterol suspension inhaler, with Cipla's and the Indian listings' points added where they differ:
- Prime a new inhaler by spraying into the air, away from your face. PharmEasy says release 2 to 3 puffs; the US Xopenex HFA label says 4 test sprays, shaking before each, and again if the inhaler has not been used for more than 3 days. Follow your carton leaflet.
- Take off the cap and shake the inhaler well (Truemeds and the Xopenex HFA instructions; Cipla describes the medicine as a suspension).
- Breathe out fully, away from the mouthpiece.
- Put the mouthpiece in your mouth and close your lips around it. Start to breathe in slowly and deeply, and press the canister down once while you breathe in.
- Hold your breath for about 10 seconds, or as long as is comfortable, then breathe out slowly.
- For the second puff, wait about a minute (Xopenex HFA instructions; PharmEasy says about 30 seconds), shake again and repeat.
- Rinse your mouth with water and spit it out. The Cipla label says to rinse the mouth with water "without swallowing" to help reduce the risk of thrush.
Spacer. The Cipla label says Aerocort Inhaler "may be used with a Zerostat VT Spacer device by patients who find it difficult to synchronize aerosol actuation with inspiration of breath". Ask your doctor or pharmacist to check your technique.
Counting puffs. Each canister holds 200 metered doses. Cipla's packaging line and the Truemeds listing describe an inhaler with a dose counter; check whether yours has one. The US Xopenex HFA label says the correct amount of medicine in each puff cannot be assured after its 200 puffs, even though the canister may not be empty; the same caution makes sense here (our note). If there is no counter, keep a tally, including test sprays. Keep the mouthpiece clean: the Xopenex HFA label says wash its plastic actuator in warm water and let it air dry at least once a week, and never get the canister wet. Do not use another product's actuator with this canister, or this actuator with another canister (our advice, based on the same label).
Check the strength on the canister. PharmEasy also lists an older, out of stock Aerocort inhaler that contained salbutamol 100 mcg with beclometasone 50 mcg. The product we sell should read beclometasone dipropionate 50 mcg with levosalbutamol 50 mcg; tell us if yours does not.
Storage. The Cipla label says store below 30°C and do not freeze. Apollo says 15 to 30°C; PharmEasy says a cool, dry place away from direct sunlight and heat. Truemeds gives both below 30°C and below 25°C on the same page. Our parcels are not temperature controlled. Never puncture or burn a pressurised canister, even when empty (our advice).
Groups who need extra care
- People coming off steroid tablets: the Cipla label says that for "patients who are steroid-dependent, it is advisable to commence therapy with beclomethasone dipropionate as a separate inhaler". It also says deaths due to adrenal insufficiency have occurred during and after transfer from steroid tablets to inhaled steroids, that people maintained on 20 mg or more of prednisone a day may be most susceptible, and that people recently weaned off steroid tablets "should also be given a supply of oral steroids to use in an emergency".
- Children under 12: the Cipla label gives a dose for adults and adolescents 12 years and above only. Cipla's Aerocort Rotacap is labelled from age 4. A child's treatment is a decision for the child's doctor. Inhaled steroids "may cause a reduction in growth velocity" in children, so the label says to monitor growth routinely.
- Heart disease, high blood pressure or an irregular heartbeat; seizures; an overactive thyroid; diabetes: the Cipla label says levosalbutamol should be used with caution. It can raise heart rate and blood pressure and may produce significant low potassium in some patients, "usually transient".
- Weak bones or risk factors for them, and eye problems: the label says people with major risk factors for low bone density should be monitored, and that glaucoma, raised eye pressure, blurred vision and cataracts have been reported with long-term inhaled steroids, so close monitoring is warranted in people with a change in vision or a history of these problems.
- Kidney problems and older people: the Cipla label says salbutamol is substantially excreted by the kidneys and the risk of toxic reactions may be greater with impaired kidney function, that caution should be used with high doses of levosalbutamol in kidney impairment, and that dose selection for an elderly patient should be cautious.
- Pregnancy: the Cipla label says levosalbutamol should be used in pregnancy "only if the potential benefit justifies the potential risk to the foetus", and that beclometasone "should only be considered if the expected benefit to the mother is greater than any possible risk to the foetus". It also says poorly or moderately controlled asthma raises the risk of pre-eclampsia, prematurity and low birth weight. Do not stop asthma treatment without advice.
- Breastfeeding: the Cipla label says it is not known whether levosalbutamol passes into human milk, and that other inhaled steroids have been detected in human milk. Talk to your doctor.
Medicines that interact (Cipla label, Drug Interactions):
- Other short-acting relievers of the same type (such as salbutamol) or adrenaline (epinephrine): "should not be used concomitantly" (see the section above on the separate reliever).
- Beta blockers, including for the heart: they block the effect and may produce severe bronchospasm; "patients with asthma should not normally be treated with beta-blockers". Where there is no acceptable alternative, such as after a heart attack, cardioselective beta blockers "should be considered", given with caution.
- Loop and thiazide diuretics (water tablets): low potassium and ECG changes can be acutely worsened; the label advises caution and says to consider monitoring potassium.
- Digoxin: racemic salbutamol lowered digoxin levels by 16% to 22% in volunteers; the label says it would be prudent to carefully evaluate digoxin levels.
- MAO inhibitors and tricyclic antidepressants, or within 2 weeks of stopping them: "extreme caution"; consider another treatment.
- Strong CYP3A inhibitors such as ritonavir and cobicistat: beclometasone is less dependent on this pathway than some other steroids, but systemic effects "cannot be excluded, and therefore caution and appropriate monitoring is advised" (Cipla label; the UK Clenil Modulite label 4.5 uses the same words).
Side effects
The Cipla label says the side effects of each ingredient may be expected. It lists, for beclometasone, thrush of the mouth and throat, hoarseness and throat irritation, upper respiratory tract infection, cough, headache and others as common, and for levosalbutamol, pain, dizziness, asthma, pharyngitis and rhinitis in adults and adolescents. Reports after approval include irregular heart rhythms, chest pain, and allergic reactions including angioedema and anaphylaxis (levosalbutamol), and aggression, depression, sleep problems, hyperactivity and suicidal thoughts, mainly in children (beclometasone).
No trial table exists for Aerocort. The two US label tables below are for each ingredient alone, in different inhalers, so they show the kind and rough size of effects, not Aerocort's rates.
| Levalbuterol inhaler, adults and adolescents, two 8 week trials (US Xopenex HFA label, Table 1) | Xopenex HFA 90 mcg (403) | Racemic albuterol 180 mcg (179) | Placebo (166) |
|---|---|---|---|
| Asthma (worsening reported as an adverse event) | 9% | 7% | 6% |
| Pharyngitis (sore throat) | 8% | 2% | 2% |
| Rhinitis (runny or blocked nose) | 7% | 2% | 3% |
| Pain | 4% | 3% | 4% |
| Dizziness | 3% | 1% | 2% |
The table lists reactions at 2% or more on levalbuterol and more often than on placebo, whether or not related to the drug.
| Beclometasone inhaler, adults and adolescents, 3 placebo-controlled trials (US QVAR RediHaler label, Table 1), by total daily dose | 80 mcg (90) | 160 mcg (92) | 320 mcg (214) | 640 mcg (211) | Placebo (304) |
|---|---|---|---|---|---|
| Oral thrush (candidiasis) | 0% | 2% | 3% | 7% | under 1% |
| Upper respiratory tract infection | 3% | 3% | 4% | 3% | 2% |
| Nasopharyngitis | 4% | 2% | 1% | 1% | 1% |
| Throat pain (oropharyngeal pain) | 2% | 2% | under 1% | 1% | under 1% |
Selected rows, QVAR RediHaler columns only. Thrush became more common as the daily dose rose. The UK Clenil Modulite label also says mouth and throat thrush increases at doses above 400 micrograms a day, and that rinsing the mouth after use may help. We have not added a chart: there are no Aerocort trial data to chart.
When to get urgent help
- A severe asthma attack, or breathing that does not improve with your reliever: call emergency services now (911 in the US and Canada, 999 in the UK, 000 in Australia) or go to the nearest emergency department (our advice). Aerocort is not for acute attacks (Cipla label), and the label tells patients to contact their physician immediately if asthma episodes do not respond to bronchodilators.
- Wheezing or breathlessness that gets worse straight after a dose (paradoxical bronchospasm): stop Aerocort and get medical help now. The Cipla label says this may be life-threatening and "frequently occurs with the first use of a new dosage".
- Asthma that keeps getting worse, or needing doses more often than usual: the label says this may be a marker of destabilization of asthma and needs a review of your treatment. See a doctor the same day (our advice).
- Swelling of the face, lips, tongue or throat, hives or rash, or trouble breathing: signs of an allergic reaction. Stop Aerocort and get medical help right away.
- Chest pain, a very fast or irregular heartbeat, fainting or a seizure.
- Using far more than prescribed. The label says "Fatalities have been reported in association with excessive use of inhaled sympathomimetic drugs in patients with asthma", and lists seizures, angina (chest pain), a fast heartbeat, irregular heart rhythms and low potassium among the expected symptoms of overdose.
- After coming off steroid tablets: tiredness, weakness, nausea and vomiting or low blood pressure, especially during an infection, injury or surgery, can be signs of adrenal insufficiency (Cipla label). Get medical help the same day, and tell the doctor about your steroid use (our advice).
- Exposure to chickenpox or measles if you have not had them or been immunised: these can have a more serious or even fatal course in people on steroids. Contact a doctor without delay (US QVAR label 5.4, 17; the Cipla label gives the same warning about how serious these infections can be).
Tell the emergency staff what you used, how many puffs and when.
Who should not use Aerocort Inhaler
Never use it (contraindications in the Cipla label):
- if you are allergic to beclometasone, levosalbutamol or any ingredient of the inhaler; the label says reactions to levosalbutamol have included hives, angioedema, rash, bronchospasm, anaphylaxis and swelling of the mouth and throat;
- as the main treatment of status asthmaticus or other acute asthma episodes where intensive measures are needed.
Use with caution, if at all (Cipla label):
- active or quiescent tuberculosis of the airways (the label's contraindications section also says "Special care is necessary" here); untreated fungal, bacterial, parasitic or viral infections throughout the body; or herpes infection of the eye.
Not covered by the label:
- children under 12 (the Cipla label gives a dose for 12 years and above);
- people dependent on steroid tablets starting treatment: the label advises starting beclometasone as a separate inhaler;
- COPD: the Cipla label is for asthma only.
Talk to a doctor first:
- if you take a beta blocker, a diuretic, digoxin, an MAO inhibitor or tricyclic antidepressant, ritonavir or cobicistat, or another reliever (see above);
- heart disease, high blood pressure, seizures, an overactive thyroid, diabetes, kidney problems, weak bones, glaucoma or cataracts;
- if you are pregnant or breastfeeding;
- if you have not had chickenpox or measles or been immunised against them.
Prescription and legal status
We found no beclometasone with levosalbutamol product approved by the FDA, the MHRA, the TGA or Health Canada, and none with beclometasone and salbutamol either. In the UK, the NHS dictionary of medicines lists GSK's Ventide inhaler (salbutamol 100 micrograms with beclometasone 50 micrograms per dose) as discontinued and not available, and the emc returned no beclometasone with salbutamol product. Health Canada's Drug Product Database lists no levalbuterol (levosalbutamol) product and no Aerocort, Ventide or Airsupra (searched 21 October and 5 November 2026), and we could not confirm any Australian registration of either combination. The single ingredients are prescription medicines where they are licensed: beclometasone inhalers are prescription only in the US (QVAR), the UK (Clenil Modulite is listed on the emc as a prescription only medicine), Canada (QVAR) and Australia (healthdirect lists Qvar as Schedule 4, prescription only), and levalbuterol inhalers are prescription medicines in the US. Indian listings mark Aerocort Inhaler as needing a prescription (Truemeds, Apollo, Medkart).
In India, we did not find this combination in the CDSCO lists of fixed dose combinations approved by the Drugs Controller General that we checked (1961 to March 2025, with some gaps). In May 2026 India's expert committee on pulmonary medicines reviewed a Cipla salbutamol 90 mcg with budesonide 80 mcg inhaler; it noted that this combination "is already approved in the USA", said no clinical safety and efficacy data had been presented in the Indian population, and recommended a phase 3 trial. In the US the FDA says personal importation of unapproved medicines is illegal in most circumstances. Asthma needs regular review by a doctor or nurse and a written action plan. Check the rules where you live.
Buying genuine Aerocort
The MHRA warns: "Any medicine not authorised for sale in the UK can be unsafe or ineffective and there is no way of knowing what is in them or the negative health effects they can have." It also advises: "Only use UK-registered pharmacies, including online pharmacies displaying the official green cross logo." That warning covers this product. When your order arrives, check that the carton and canister name Cipla, Aerocort and beclometasone dipropionate 50 mcg with levosalbutamol 50 mcg, with a batch number and an expiry date, and that the canister is undamaged. These checks cannot prove a product is genuine, because counterfeiters copy packaging. If your asthma control gets worse after a change of supply, see a doctor rather than taking extra puffs. If a batch causes unusual symptoms, seek medical advice and report it to your medicines regulator (the MHRA Yellow Card scheme in the UK, FDA MedWatch in the US, the TGA in Australia or Health Canada) as well as to us.
Delivery
We ship Aerocort Inhaler to the US, UK, Australia and Canada in plain packaging with tracking. Standard delivery takes 7 to 14 business days to most countries. Never let a parcel from us be your only source of asthma medicine: keep a reliever your doctor has agreed and order at least three weeks before your supply runs out. Shipping costs a flat $25 on orders under $149 and is free from $149. See our shipping page and refund policy.
Related guides
- Salbutamol vs levosalbutamol: what the enantiomer evidence shows
- Rotacaps vs inhaler vs respules: which device gets the dose into your lungs
- Budesonide with formoterol inhalers: doses, MART and the trials
- Prednisolone for asthma flare-ups: dose, course length and risks
Other asthma products: Levolin 0.63mg Respules (levosalbutamol) and Budecort 0.5mg Respules (budesonide). See also our asthma treatment overview.
Sources
- Cipla Limited. Aerocort Inhaler (beclomethasone dipropionate 50 mcg + levosalbutamol 50 mcg per actuation) prescribing information, last updated January 2019, checked 5 November 2026: composition, dosage form, description, indications, dosage and administration, contraindications, warnings and precautions, drug interactions, pregnancy, lactation, paediatric and geriatric use, undesirable effects, overdosage, storage, packaging. Ciplamed
- Cipla Limited. Aerocort Rotacaps prescribing information, last updated March 2019, and Aerocort Forte Rotacaps prescribing information, date of revision 23 September 2024. Ciplamed
- QVAR RediHaler (beclomethasone dipropionate HFA), Teva, US prescribing information, DailyMed version of 14 September 2026, sections 1, 2, 4, 5, 6.1, 12.3, 16 and 17. DailyMed
- Xopenex HFA (levalbuterol tartrate), Lupin, US prescribing information and patient instructions, DailyMed version of 30 July 2025, sections 1, 2, 6.1, 14, 16 and 17. DailyMed
- Airsupra (albuterol and budesonide), AstraZeneca, US prescribing information, DailyMed version of 22 September 2025, sections 1, 2.1 and 16. DailyMed
- Clenil Modulite 100 micrograms inhaler, Chiesi, UK summary of product characteristics, sections 4.5 and 4.8 (emc, updated 3 April 2023). emc
- Global Initiative for Asthma. GINA Summary Guide 2026: reliever recommendations, Track 2, medication tables and Table 6 (inhaled corticosteroid doses). GINA
- Papi A, et al. Rescue use of beclomethasone and albuterol in a single inhaler for mild asthma. N Engl J Med 2007. PMID 17507703. PubMed
- Martinez FD, et al. Use of beclomethasone dipropionate as rescue treatment for children with mild persistent asthma (TREXA). Lancet 2011. PMID 21324520. PubMed
- NHS Business Services Authority, dm+d: Ventide inhaler (GlaxoSmithKline UK Ltd), accessed 21 October 2026. dm+d
- Health Canada Drug Product Database, searched 21 October and 5 November 2026; healthdirect Australia, Qvar Inhaler, accessed 21 October 2026. Health Canada DPD, healthdirect
- Central Drugs Standard Control Organisation. Fixed dose combinations approved by DCG(I), lists from 1961 to March 2025, searched 21 October and 5 November 2026; Recommendations of the SEC (Pulmonary), meeting of 14 May 2026, item 8. CDSCO
- Centers for Medicare and Medicaid Services. National Average Drug Acquisition Cost (NADAC), QVAR RediHaler, levalbuterol tartrate inhaler, Xopenex HFA and Airsupra, rates effective 21 October 2026 (file of 4 November 2026). data.medicaid.gov
- Truemeds, PharmEasy, Apollo Pharmacy and Medkart. Aerocort Inhaler (Cipla) listings, accessed 5 November 2026. Truemeds, PharmEasy
- MHRA. 20 million illegal erectile dysfunction pills seized as MHRA warns against risky online buys, 13 February 2026. GOV.UK
- US Food and Drug Administration. Personal Importation. FDA
This page is for information and is not medical advice. Aerocort Inhaler contains a steroid and a reliever; your doctor should decide whether it fits your asthma plan and how to use it.
Frequently asked questions
What is Aerocort Inhaler?
Aerocort Inhaler is a pressurised metered dose inhaler made in India by Cipla. Each puff delivers beclometasone dipropionate 50 mcg, an inhaled steroid preventer, and levosalbutamol 50 mcg, a short-acting reliever (called levalbuterol in the US). One canister holds 200 metered doses. Cipla labels it for asthma in adults and adolescents aged 12 and above.
Is there a US, UK, Canadian or Australian version of Aerocort Inhaler?
Not that we could find. We found no beclometasone with levosalbutamol or beclometasone with salbutamol inhaler approved by the FDA, MHRA or Health Canada, and could not confirm one with the TGA in Australia. The UK once had GSK's Ventide inhaler (salbutamol with beclometasone), but the NHS dictionary of medicines lists it as discontinued. The nearest US product, Airsupra, contains different medicines (albuterol with budesonide) and is approved only for as-needed use in adults.
How much does Aerocort Inhaler cost?
As of November 2026, one inhaler costs $11.00, two cost $22.00 and three cost $30.00. With 200 puffs a canister, that is $0.055 a puff for one or two inhalers and $0.05 for three, before shipping. All packs are under $149, so $25 shipping applies, which brings the cost to $36.00, $23.50 and $18.33 an inhaler. The pack selector shows the current price.
How do I use Aerocort Inhaler?
Cipla's label says two inhalations three or four times daily for people aged 12 and above, titrated to the lowest effective dose, but it gives no step by step instructions, so follow the leaflet in your carton. The usual steps for a pressurised inhaler, taken from the US instructions for a different product (Xopenex HFA), are: prime a new inhaler, shake it, breathe out, then press the canister once as you start a slow, deep breath in and hold your breath for about 10 seconds; wait about a minute before the second puff. Cipla's label says to rinse your mouth with water without swallowing afterwards, and that a Zerostat VT spacer may help if timing the press is hard. Follow the dose your doctor gives you.
How long does one Aerocort Inhaler last?
At the Cipla label dose of 6 to 8 puffs a day, a 200 dose canister lasts about 25 to 33 days, and a little less once test sprays are counted (our arithmetic). Two inhalers last about 50 to 66 days and three about 75 to 100 days. Check the dose counter if yours has one, or keep a tally.
Can I use Aerocort Inhaler as a reliever during an asthma attack?
No. Cipla's label says it is not for use in acute attacks and that some patients will need a separate levosalbutamol inhaler. A severe attack, or one your reliever does not help, needs emergency care: call 911 in the US and Canada, 999 in the UK or 000 in Australia. Asthma guidelines (GINA) support as-needed steroid plus reliever combinations for some adults and adolescents, but Cipla's label does not describe that use for Aerocort, so it is a decision for your doctor.
Why do asthma guidelines worry about the labelled dose?
Taking two puffs three or four times a day means taking a short-acting reliever on a regular schedule. The GINA 2026 Summary Guide says regular use of short-acting relievers is not recommended, because within 1 to 2 weeks it increases airway hyperresponsiveness and inflammation and reduces the response to the reliever. This is our reading of how the label and the guideline fit together, and it is why we would not recommend this product; discuss it with your doctor before you start or stop anything.
What are the side effects of Aerocort Inhaler?
The Cipla label lists thrush of the mouth and throat, hoarseness, throat irritation, upper respiratory tract infection, cough and headache as common with beclometasone, and pain, dizziness, asthma (reported as a side effect), sore throat and runny or blocked nose with levosalbutamol. Levosalbutamol can also cause a fast heartbeat, tremor and low potassium. Get urgent help for wheezing that gets worse straight after a dose, chest pain, a very fast or irregular heartbeat or signs of an allergic reaction.
Who should not use Aerocort Inhaler?
Do not use it if you are allergic to beclometasone, levosalbutamol or any ingredient, or as the main treatment of a severe acute attack. The Cipla label says to use inhaled steroids with caution, if at all, with tuberculosis of the airways, untreated infections throughout the body or herpes infection of the eye, and that people with asthma should not normally take beta blockers. It has no dose for children under 12. Talk to a doctor first if you have heart disease, high blood pressure, seizures, an overactive thyroid, diabetes, glaucoma or cataracts, or are pregnant or breastfeeding.
Do I need a prescription for Aerocort Inhaler?
Indian listings (Truemeds, Apollo, Medkart) mark it as needing a prescription. The combination is not approved by the FDA, MHRA, TGA or Health Canada, and its single ingredients are prescription medicines where they are licensed. In the US, the FDA says personal importation of unapproved medicines is illegal in most circumstances. Check the rules where you live, and use it only on a plan agreed with your doctor.
How long does delivery take?
We ship to the US, UK, Australia and Canada in plain packaging with tracking. Standard delivery takes 7 to 14 business days. Shipping is $25 on orders under $149 and free from $149. Never let a parcel from us be your only source of asthma medicine: keep a reliever your doctor has agreed and order at least three weeks before you run out.
Medical References
- 1.Aerocort Inhaler (beclomethasone dipropionate 50 mcg + levosalbutamol 50 mcg): prescribing information, Cipla Limited (last updated January 2019)
- 2.QVAR RediHaler (beclomethasone dipropionate HFA): US prescribing information, Teva (DailyMed) — 2026
- 3.Xopenex HFA (levalbuterol tartrate) inhalation aerosol: US prescribing information, Lupin (DailyMed) — 2025
- 4.Airsupra (albuterol and budesonide) inhalation aerosol: US prescribing information, AstraZeneca (DailyMed) — 2025
- 5.Clenil Modulite 100 micrograms inhaler: UK Summary of Product Characteristics, Chiesi (emc) — 2023
- 6.Global Initiative for Asthma: GINA Summary Guide 2026
- 7.Papi A, et al. Rescue use of beclomethasone and albuterol in a single inhaler for mild asthma. N Engl J Med 2007 (PMID: 17507703) — 2007
- 8.Martinez FD, et al. Use of beclomethasone dipropionate as rescue treatment for children with mild persistent asthma (TREXA). Lancet 2011 (PMID: 21324520) — 2011
- 9.NHS dm+d: Ventide inhaler (salbutamol 100 micrograms / beclometasone 50 micrograms), GlaxoSmithKline UK, discontinued
- 10.CMS National Average Drug Acquisition Cost (NADAC): QVAR RediHaler, levalbuterol tartrate HFA, Xopenex HFA, Airsupra (rates effective 2026-10-21) — 2026
- 11.US Food and Drug Administration: Personal Importation
Sources: U.S. National Library of Medicine (DailyMed, PubMed), openFDA
Related articles
Customer Reviews
No reviews yet. Bought Aerocort Inhaler? Tell other buyers how it went.







